Paasa Logo
Transgene S.A. logo
TNGPARMarket closedOpens 9:00am CET

Transgene S.A.

€0.73Last updated
-€0.03 (3.95%)Past day
Timezone

Transgene S.A. (PAR: TNG) is trading at €0.73, about ₹80 at today's EUR/INR rate, as of 28 Sep 2026, 11:35 AM ET, down 3.95% today. Indian residents can buy Transgene from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:€0.76
Previous close:€0.76
Volume:158.20K

Today's low

€0.73

Today's high

€0.76

52 week low

€0.71

52 week high

€1.50

TNG opened at €0.76, closed previously at €0.76, and has traded between €0.71 and €1.50 over the past 52 weeks.

About

Transgene SA, a French biotechnology firm headquartered in Illkirch-Graffenstaden, specializes in designing and developing groundbreaking therapeutic vaccines and oncolytic viruses to combat cancer and infectious diseases. Founded in 1979 and operating as a subsidiary of TSGH SAS, the company maintains a robust pipeline of treatments. This includes TG4050, a therapeutic vaccine in Phase I clinical trials for ovarian cancer and HPV-negative head and neck cancers, and TG4001, another therapeutic vaccine currently in Phase II for HPV-positive cancers. Its oncolytic virus programs feature TG6002, undergoing Phase I/IIa trials for various solid tumors, specifically gastrointestinal adenocarcinomas impacting the stomach, pancreas, and colon, as well as BT-001, an oncolytic virus in Phase I/II for solid tumors. Furthermore, Transgene is progressing TG1050, a therapeutic vaccine for chronic hepatitis B, and Pexa-Vec, an oncolytic virus targeting solid tumors. The company has established a comprehensive network of partnerships, encompassing strategic collaborations with major players like AstraZeneca, Merck KGaA, Pfizer, PersonGen BioTherapeutics, and NEC Corporation, alongside licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva, and additional agreements with Sanofi, BioInvent, and Randox.

Country
FR
CEO
Alessandro Riva
Exchange listed on
PAR
Industry
Biotechnology
Base currency
EUR
Full Time Employees
145
Sector
Healthcare
IPO date
12/04/2000

Key statistics

Avg. volume

76.54K

Market cap

€203.13M

P/E Ratio

-4.37

Price-to-sales ratio

648.97

Enterprise value

€201.06M

Free cash flow yield

-19.34%

Debt-to-equity ratio

0.02

Return on equity

-29.36%

ROIC

-29.72%

Beta

0.69

Dividend yield

0.00%

Last dividend

€0.00

Financial overview

Revenue

€490.00K

Earnings per share

-€0.26

Free cash flow

-€37.58M

Net profit margin

-10830.03%

Gross margin

4415.65%

EBITDA

-€39.77M

Revenue growth

-92.29%

Similar securities

This is not an investment recommendation

How to buy Transgene from India

Indian residents can buy Transgene shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.

  3. Search for Transgene and place an order

    Find Transgene by name or by its ticker, TNG, and choose an order type. Transgene trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Transgene position in EUR and INR. Transgene pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Transgene from India

Trading and taxes when buying Transgene from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneTransgene does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Transgene stock?

Yes. Transgene (TNG) has been listed on Euronext Paris since 2000, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Transgene share cost in rupees?

One Transgene share is €0.73 — about ₹80 at an EUR/INR rate of 109.29 on 28 Sep 2026. Both the Transgene price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Transgene from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Transgene shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Transgene price. Paasa issues a capital-gains statement for your return.

Does Transgene pay a dividend?

No. Transgene does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Transgene from India?

Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.

Do I have to declare Transgene shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Transgene holding, its cost and its closing value.

How do I sell Transgene and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on Transgene?

Yes. Transgene is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.